We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Safety monitoring and information (97)
- Advertising (272)
- COVID-19 (163)
- Legislation (93)
- Compliance and enforcement (65)
- Vaping hub (53)
- Manufacturing (52)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
126 result(s) found, displaying 101 to 125
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Regulatory decision noticesMore applications for Good Manufacturing Practice (GMP) clearances can now be assessed under the TGA’s MRA pathway.
-
Safety updatesHealth professionals should check if patients undergoing general anaesthesia have used products containing pholcodine in the previous 12 months.
-
Media releasesFollowing a safety investigation into pholcodine the TGA are cancelling 55 products (from the ARTG) and recalling them from pharmacy shelves due to an increased risk of anaphylactic reactions.
-
News articlesBefore you take a weight loss supplement or medicine, there are things to consider.
-
BlogMake small changes to how you think about paracetamol.
-
News articlesThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
Media releasesConsumers are advised to be cautious about ivermectin products that are sold by unverified online stores.
-
BlogEven if you're familiar with your pet's medicine, the advice is clear: if a product is labelled 'for animal use only', do not take it.
-
-
BlogHow to find information about the inactive ingredients in your medicines.
-
News articlesIn response to the COVID-19 pandemic, the TGA is implementing Serious Shortage Medicine Substitution Notices
-
News articlesInterim statement concerning the use of GS1 Australia's Recall Health platform
-
Media releasesCommunity pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines
-
-
BlogCounterfeit medicines pose a health risk, but our tips can help you spot them.
-
BlogBe informed and aware, but don’t be afraid.
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
BlogTim's story explains the risks of buying SARMs online.
-
News articlesAustralian launch of a new product called Nyxoid nasal spray for opioid overdoses
-
BlogFor some people, vitamins are an important part of their health. Learn how the TGA regulates vitamins.
-
Regulatory decision noticesMake a request under section 9D of the Therapeutic Goods Act 1989.
-
Safety updatesIn this issue: Action after registry data analysis; Environmental extremes; Button battery dangers; Infant sleep positioners reviewed
-
Media releasesPharmacy software vendor links to TGA adverse event reporting web service